BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15864115)

  • 1. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
    Terra SG; Hamilton KK; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hill JA; Aranda JM; Yarandi HN; Johnson JA
    Pharmacogenet Genomics; 2005 Apr; 15(4):227-34. PubMed ID: 15864115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.
    Parikh KS; Fiuzat M; Davis G; Neely M; Blain-Nelson P; Whellan DJ; Abraham WT; Adams KF; Felker GM; Liggett SB; O'Connor CM; Bristow MR
    Circ Genom Precis Med; 2018 Aug; 11(8):e002210. PubMed ID: 30354340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.
    Lee HY; Chung WJ; Jeon HK; Seo HS; Choi DJ; Jeon ES; Kim JJ; Shin JH; Kang SM; Lim SC; Baek SH
    Korean J Intern Med; 2016 Mar; 31(2):277-87. PubMed ID: 26879662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Genetic Polymorphisms in the Beta-1 Adrenergic Receptor with Recovery of Left Ventricular Ejection Fraction in Patients with Heart Failure.
    Luzum JA; English JD; Ahmad US; Sun JW; Canan BD; Sadee W; Kitzmiller JP; Binkley PF
    J Cardiovasc Transl Res; 2019 Aug; 12(4):280-289. PubMed ID: 30756358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis.
    Liu WN; Fu KL; Gao HY; Shang YY; Wang ZH; Jiang GH; Zhang Y; Zhang W; Zhong M
    PLoS One; 2012; 7(7):e37659. PubMed ID: 22815685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
    Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.
    Wagoner LE; Craft LL; Zengel P; McGuire N; Rathz DA; Dorn GW; Liggett SB
    Am Heart J; 2002 Nov; 144(5):840-6. PubMed ID: 12422153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of β₁-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration.
    Kindermann M; Seeland U; Ruhnke P; Böhm M; Maack C
    Clin Res Cardiol; 2011 Feb; 100(2):129-37. PubMed ID: 20821015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the beta adrenergic receptor predict left ventricular remodeling following acute myocardial infarction.
    McLean RC; Hirsch GA; Becker LC; Kasch-Semenza L; Gerstenblith G; Schulman SP
    Cardiovasc Drugs Ther; 2011 Jun; 25(3):251-8. PubMed ID: 21626217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
    Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
    Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure].
    Yu WP; Lou M; Deng B; Song HM; Wang HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):776-80. PubMed ID: 17217681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of phenotype and pharmacokinetics on beta-blocker drug target pharmacogenetics.
    Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
    Pharmacogenomics J; 2006; 6(3):174-8. PubMed ID: 16402084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.